Dr. Chapman provides patent and intellectual property services to clients on pharmaceutical, chemistry, biotechnology, and medical device matters.
He is experienced in drafting patent applications, proactively prosecuting domestic and foreign patent applications, and assisting with due diligence and freedom-to-operate assessments. Dr. Chapman is committed to providing responsive client service utilizing the firm’s collective legal and scientific capabilities. Since joining the firm in 2013, he has worked with a variety of clients including startup biotechnology, chemistry, and medical device companies; large pharmaceutical companies; academic institutions; and independent inventors. He is also advancing his patent law and general legal knowledge through his patent case law and law school studies.
Dr. Chapman’s scientific education includes studies in medicinal chemistry, proteomics, mass spectrometry instrumentation and application, biochemistry, pharmacology, molecular biology, and chemistry. His technical background also includes training and research conducted at: the David R. Goodlett Laboratory (utilized mass spectrometry instrumentation to identify novel protein pathway responses and protein post-translational modifications); Amgen (utilized mass spectrometry instrumentation to study antibody-drug conjugates); and the Southwest Environmental Health Sciences Center (studied protein adduction by environmental toxicants).
He is admitted to practice before the U.S. Patent & Trademark Office.
©1996-2018 Morrison & Foerster LLP. All rights reserved.